COMP <GO>
GCO vs PG // FORWARD P/E MULTIPLE
Genesco Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: GCO 4
— PG 9
▲ FORWARD P/E MULTIPLE LEADER: PG
LAST: $37.76 (+1.92%) • MKT CAP: $408.6M
forward-pe
29.2x
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GCO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GCO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.30% | 51.20% | -4.90 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 25.40% | -22.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.4x | 16.2x | -11.80 | GCO | /valuation <GO> |
| Free Cash Flow Yield | 20.49% | 3.77% | +16.72 | GCO | /fcf-yield <GO> |
| Operating Margin | 0.70% | 24.30% | -23.60 | PG | /operating-margins <GO> |
| Net Profit Margin | 0.50% | 19.00% | -18.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.80% | 0.30% | +4.50 | GCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.56 | 5.59 | -3.03 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | GCO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.2 | 60.3 | -0.10 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.2x | 21.7x | +7.50 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $408.6M | $372.21B | -$371.80B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GCO REV | PG REV | GCO GROSS % | PG GROSS % | GCO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $84.28B | 46.3% | 51.2% | $83.7M | $14.04B |
| FY 2024 | $2.33B | $84.04B | 47.2% | 51.4% | $46.8M | $16.52B |
| FY 2023 | $2.32B | $82.01B | — | — | $94.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GCO // BETA —
PG // BETA 0.87